(Q37268536)

19 August 2017

1 reference

title

Pharmacokinetics of newer drugs in patients with renal impairment (Part II). (English)

1 reference

19 August 2017

1 reference

Singlas E

1

1 reference

PubMed ID

1879096

19 August 2017

Fillastre JP

series ordinal

2

1 reference

19 August 2017

1 May 1991

1 reference

Clinical Pharmacokinetics

19 August 2017

1 reference

19 August 2017

20

1 reference

19 August 2017

5

1 reference

19 August 2017

389-410

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199120050-00004

19 August 2017

0 references

cites work

Pharmacokinetics of esmolol and ASL-8123 in renal failure

1 reference

12 December 2020

Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension

1 reference

12 December 2020

The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily

1 reference

12 December 2020

Guanadrel Sulfate: A Postganglionic Sympathetic Inhibitor for the Treatment of Mild to Moderate Hypertension

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment

1 reference

12 December 2020

Clinical pharmacokinetics of prazosin--1985.

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects

1 reference

12 December 2020

The clinical pharmacokinetics of quinapril

1 reference

12 December 2020

Elimination kinetics of captopril in patients with renal failure

1 reference

12 December 2020

Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man

1 reference

12 December 2020

Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension

1 reference

12 December 2020

Pharmacokinetics of intravenous cilazaprilat in normal volunteers

1 reference

12 December 2020

Felodipine kinetics in healthy men.

1 reference

12 December 2020

Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs

1 reference

12 December 2020

Nitrendipine kinetics in normal and impaired renal function

1 reference

12 December 2020

Pharmacokinetics of cetamolol in hypertensive patients with normal and compromised renal function

1 reference

12 December 2020

Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension

1 reference

12 December 2020

Clinical pharmacokinetics of urapidil

1 reference

12 December 2020

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

1 reference

12 December 2020

Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.

1 reference

12 December 2020

Kinetics of fenoximone, a new cardiotonic, in healthy subjects

1 reference

12 December 2020

Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline

1 reference

12 December 2020

Oral and intravenous pharmacokinetics of milrinone in human volunteers

1 reference

12 December 2020

Pharmacokinetics of amlodipine in renal impairment

1 reference

12 December 2020

The pharmacokinetics of oral isradipine in normal volunteers

1 reference

12 December 2020

Elimination and haemodynamic effects of nitrendipine in patients with chronic renal failure

1 reference

12 December 2020

Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failure

1 reference

12 December 2020

Clinical pharmacokinetics of ibopamine on different diseases and conditions

1 reference

12 December 2020

Haemodialysis does not affect the pharmacokinetics of nifedipine

1 reference

12 December 2020

Propafenone disposition in renal insufficiency and renal failure

1 reference

12 December 2020

Amlodipine pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

1 reference

12 December 2020

The effect of renal function on enalapril kinetics

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

Influence of genetic polymorphism on the metabolism and disposition of encainide in man

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug

1 reference

12 December 2020

Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin

1 reference

12 December 2020

The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance

1 reference

12 December 2020

Clinical pharmacokinetics of the newer ACE inhibitors. A review

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

Treatment of hypertension with lisinopril in end-stage renal failure

1 reference

12 December 2020

The effects of renal function on the disposition of isradipine

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

1 reference

12 December 2020

Clinical pharmacokinetics of nimodipine in normal and impaired renal function

1 reference

12 December 2020

Oral flecainide pharmacokinetics in patients with impaired renal function

1 reference

12 December 2020

Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease

1 reference

12 December 2020

Absorption, distribution and elimination of mexiletine

1 reference

12 December 2020

Clinical pharmacology of propafenone

1 reference

12 December 2020

Pharmacokinetics of flecainide acetate in patients with severe renal impairment

1 reference

12 December 2020

Kinetics of the oral antiarrhythmie lidocaine congener, tocainide

1 reference

12 December 2020

Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.

1 reference

12 December 2020

Pharmacokinetics of nisoldipine in renal dysfunction

1 reference

12 December 2020

Effect of renal impairment on the pharmacokinetics of cibenzoline.

1 reference

12 December 2020

Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension

1 reference

12 December 2020

Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug

1 reference

12 December 2020

Pirmenol kinetics and effective oral dose

1 reference

12 December 2020

Effect of renal impairment on disposition of pentopril and its active metabolite

1 reference

12 December 2020

Oral bioavailability and intravenous pharmacokinetics of amrinone in humans

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of newer inotropic agents

1 reference

12 December 2020

Pharmacokinetics of cibenzoline in patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of rilmenidine in healthy subjects

1 reference

12 December 2020

Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent

1 reference

12 December 2020

Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function

1 reference

12 December 2020

Disposition of guanadrel in subjects with normal and impaired renal function

1 reference

12 December 2020

Clinical pharmacokinetics of clonidine

1 reference

12 December 2020

Ibopamine kinetics after a single oral dose in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of felodipine in patients with impaired renal function

1 reference

12 December 2020

Encainide disposition in patients with renal failure

1 reference

12 December 2020

Pharmacokinetics of carteolol in relation to renal function

1 reference

12 December 2020

Lisinopril pharmacokinetics in chronic renal failure

1 reference

12 December 2020

The influence of renal function on clinical pharmacokinetics of moxonidine

1 reference

12 December 2020

Pharmacokinetics of intravenous enoximone in dialysis patients

1 reference

12 December 2020

Pharmacokinetics of cilazapril in patients with renal failure

1 reference

12 December 2020

Pharmacokinetics of rilmenidine

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function

1 reference

12 December 2020

Terazosin kinetics after oral and intravenous doses

1 reference

12 December 2020

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency.

1 reference

12 December 2020

Pharmacokinetics and absolute bioavailability of carteolol, a new ?-adrenergic receptor blocking agent

1 reference

12 December 2020

Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of ibopamine in patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension

1 reference

12 December 2020

Pharmacokinetics of nitrendipine in terminal renal failure

1 reference

12 December 2020

Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers.

1 reference

12 December 2020

Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.

1 reference

12 December 2020

Biotransformation and elimination of 14C-flecainide acetate in humans

1 reference

12 December 2020

The influence of urinary pH on flecainide excretion and its serum pharmacokinetics

1 reference

12 December 2020

Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite

1 reference

12 December 2020

Clinical pharmacokinetics of methyldopa

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing

1 reference

12 December 2020

The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide

1 reference

12 December 2020

Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo

1 reference

12 December 2020

Clinical pharmacokinetics of encainide

1 reference

12 December 2020

Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship

1 reference

12 December 2020

1 reference

12 December 2020

Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antiarrhythmic agents

1 reference

12 December 2020

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Investigations on the pharmacokinetics of propafenone in man

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist

1 reference

12 December 2020

Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.

1 reference

12 December 2020

Pharmacokinetics of terazosin

1 reference

12 December 2020

Pharmacokinetics of calcium antagonists under development

1 reference

12 December 2020

10.2165/00003088-199120050-00004

Identifiers

DOI

1 reference

PubMed ID

1879096

Dimensions Publication ID

19 August 2017

0 references

1 reference

PubMed ID

1879096